Is cimzia an injection or an iv infusion?

What is Cimzia and how is it administered?

Cimzia (certolizumab pegol) is a medication used to treat certain autoimmune diseases such as rheumatoid arthritis and Crohn's disease. According to the manufacturer, UCB Pharma, Cimzia is administered via subcutaneous injection once every two weeks [1].

Difference between injections and IV infusions

Injections are administered directly into the body using a needle, whereas IV infusions involve injecting a medication or treatment into a vein through an intravenous line. Cimzia is a self-administered medication, and patients are typically taught how to give themselves the injection at home [2].

Administration technique and equipment

Cimzia is given as a subcutaneous injection using a 27-gauge needle, and patients are instructed to pinch a fold of skin on their abdomen, thigh, or upper arm to inject the medication [3]. The injection is typically given at a 90-degree angle, and patients may experience some redness, swelling, or itching at the injection site.

Benefits and considerations

Cimzia has been shown to be effective in reducing inflammation and symptoms in patients with autoimmune diseases. While some patients may experience injection site reactions, these are typically mild and transient [4].

References

[1] UCB Pharma. (2022). Cimzia (certolizumab pegol) injection, for intravenous use, for subcutaneous use.

[2] FDA. (2017). Cimzia (certolizumab pegol) injection for intravenous use, for subcutaneous use prescribing information.

[3] MedlinePlus. (2022). Cimzia - injection.

[4] DrugPatentWatch.com. (2022). Cimzia (certolizumab pegol) patents.